AngioDynamics, Inc. (ANGO)
15.11
-0.01
(-0.07%)
USD |
NASDAQ |
Oct 02, 16:00
15.12
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Market Cap : 630.09M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 630.09M |
| October 01, 2026 | 630.51M |
| September 30, 2026 | 641.35M |
| September 29, 2026 | 650.53M |
| September 28, 2026 | 648.02M |
| September 25, 2026 | 645.94M |
| September 24, 2026 | 637.18M |
| September 23, 2026 | 646.77M |
| September 22, 2026 | 653.45M |
| September 21, 2026 | 643.02M |
| September 18, 2026 | 643.85M |
| September 17, 2026 | 640.94M |
| September 16, 2026 | 644.69M |
| September 15, 2026 | 653.86M |
| September 14, 2026 | 646.77M |
| September 11, 2026 | 636.77M |
| September 10, 2026 | 635.51M |
| September 09, 2026 | 638.85M |
| September 08, 2026 | 634.68M |
| September 04, 2026 | 633.85M |
| September 03, 2026 | 645.11M |
| September 02, 2026 | 651.36M |
| September 01, 2026 | 661.37M |
| August 31, 2026 | 672.63M |
| August 28, 2026 | 660.95M |
| Date | Value |
|---|---|
| August 27, 2026 | 658.03M |
| August 26, 2026 | 654.28M |
| August 25, 2026 | 665.12M |
| August 24, 2026 | 657.62M |
| August 21, 2026 | 656.78M |
| August 20, 2026 | 659.70M |
| August 19, 2026 | 670.13M |
| August 18, 2026 | 659.70M |
| August 17, 2026 | 653.45M |
| August 14, 2026 | 660.95M |
| August 13, 2026 | 653.03M |
| August 12, 2026 | 656.78M |
| August 11, 2026 | 656.78M |
| August 10, 2026 | 656.78M |
| August 07, 2026 | 654.28M |
| August 06, 2026 | 630.09M |
| August 05, 2026 | 627.17M |
| August 04, 2026 | 633.43M |
| August 03, 2026 | 632.60M |
| July 31, 2026 | 616.75M |
| July 30, 2026 | 615.91M |
| July 29, 2026 | 610.08M |
| July 28, 2026 | 597.98M |
| July 27, 2026 | 569.63M |
| July 24, 2026 | 566.71M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Boston Scientific Corp. | 61.63B |
| Penumbra, Inc. | 12.51B |
| Abbott Laboratories | 168.71B |
| Alphatec Holdings, Inc. | 1.531B |
| AtriCure, Inc. | 2.805B |
Market Cap Related Metrics
| PS Ratio | 1.959 |
| PEG Ratio | -2.686 |
| Price to Book Value | 3.688 |
| Price | 15.11 |
| Earnings Yield | -5.86% |
| PEGY Ratio | -2.686 |